
Renovacor
Transformative Therapies for Cardiovascular Disease.
Employees
Enterprise value
$53m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 Valuation: €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
* | $53.0m Valuation: $53.0m | Acquisition | |
Total Funding | 000k |

RTW Investments(exited)

Surveyor Capital(exited)

Affinity Asset Advisors(exited)

Altium Capital(exited)

Ikarian Capital LLC(exited)

Acorn Bioventures(exited)

Longview Ventures(exited)

Innogest Capital(exited)

sio capital management(exited)

South Ocean Capital Management(exited)

Chardan Healthcare Investments(exited)

Vincero(exited)

BioAdvance(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads